TY - CHAP M1 - Book, Section TI - Chapter 17A. Pharmacogenomics of Gastrointestinal Drugs: Focus on Proton Pump Inhibitors A1 - Furuta, Takahisa A1 - Sugimoto, Mitsushige A1 - Shirai, Naohito A2 - Bertino, Joseph S. A2 - DeVane, C. Lindsay A2 - Fuhr, Uwe A2 - Kashuba, Angela D. A2 - Ma, Joseph D. PY - 2013 T2 - Pharmacogenomics: An Introduction and Clinical Perspective AB - Discuss pharmacogenomics as it relates to gastroenterology with the focus on H. pylori infection.Outline the effects of genetic polymorphism on proton pump inhibitors and their efficacy in H. pylori.Illustrate how pharmacogenomics can be used to tailor therapy with proton pump inhibitors. SN - PB - The McGraw-Hill Companies CY - New York, NY Y2 - 2024/03/29 UR - accesspharmacy.mhmedical.com/content.aspx?aid=56877996 ER -